Pipeline

Research is just the beginning – and that is where it all began for CLS. We are now running various clinical studies to develop new therapies in the fight against serious diseases such as cancer.

Clinical programs

Last updated: 2024-06-27

Publications

Below you will find links to peer-reviewed publications covering the preclinical research behind imILT®, and clinical studies where our products are used.

Preclinical studies

Clinical studies

References

How it works

Our products for laser ablation are based on two different principles, both with the intention of treating patient conditions as precisely as possible, while reducing or eliminating unpleasant side effects.
Read more

About CLS

CLS is a medical technology company based in Lund, Sweden. We are committed to continuously develop more precise treatment tools for laser ablation of diseased tissue, such as tumors. Through our platform, more patients can be accurately treated based on their specific diagnosis and needs.
Read more

Welcome to Clinical Laserthermia Systems.

Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!

Please choose your country or region

Global
US

About CLS

Privacy Policy

Patent Information

News and insights

Contact

Scheelevägen 2
223 81 Lund, Sverige
+46 46-15 21 00
info@clinicallaser.se

Youtube Linkedin

©Copyright 2024 CLS AB. All rights reserved.
MM-2022-025/Rev2